EN HU

Bay Péter

Name: Bay Péter
Affiliation:
  • Debreceni Egyetem. Általános Orvostudományi Kar. Orvosi Vegytani Intézet / University of Debrecen. Faculty of Medicine. Department of Medical Chemistry
Other profiles: MTMT

Publication list

Uploaded publications:
163
Publications in DEA:
163
OA:
90
Date range:
2001-2025
2025
1.
Sipos, A., Kerekes, É., Szeőcs, D., Szarvas, F., Schwarcz, S., Tóth, E., Ujlaki, G., Mikó, E., Bai, P.: Ursodeoxycholic acid prompts glycolytic dominance, reductive stress and epithelial-to-mesenchymal transition in ovarian cancer cells through NRF2 activation.
Cell Death Discov. 11 (1), 1-10, (article identifier: 134), 2025.
Journal metrics:
Q1 Cancer Research (2024)
Q1 Cell Biology (2024)
Q1 Cellular and Molecular Neuroscience (2024)
Q1 Immunology (2024)
2024
2.
Kovács, P., Schwarcz, S., Nyerges, P., Bíró, T. I., Ujlaki, G., Bai, P., Mikó, E.: Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models.
Front. Cell. Dev. Biol. 12, 1-14, (article identifier: 1487685), 2024.
Journal metrics:
Q1 Cell Biology
Q1 Developmental Biology
3.
Szeőcs, D., Vida, B., Petővári, G., Póliska, S., Janka, E. A., Sipos, A., Uray, K., Sebestyén, A., Krasznai, Z. T., Bai, P.: Cell-free ascites from ovarian cancer patients induces Warburg metabolism and cell proliferation through TGFbeta-ERK signalling.
GeroScience. 46 (4), 3581-3597, 2024.
Journal metrics:
Q1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
Q1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
4.
Schwarcz, S., Nyerges, P., Bíró, T. I., Janka, E. A., Bai, P., Mikó, E.: Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells.
Molecules. 29 (13), 1-16, (article identifier: 3073), 2024.
Journal metrics:
Q1 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q2 Molecular Medicine
Q1 Organic Chemistry
Q1 Pharmaceutical Science
Q1 Physical and Theoretical Chemistry
5.
Tóth, E., Fagyas, M., Nagy, B. J., Mányiné Siket, I., Szőke, B., Mártha, L., Mahdi, M., Erdősi, G., Pólik, Z., Kappelmayer, J., Papp, Z., Borbély, A., Szabó, T., Balla, J., Balla, G., Bácsi, A., Szekanecz, Z., Bai, P., Tóth, A.: Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients.
GeroScience. 46 (2), 1561-1574, 2024.
Journal metrics:
Q1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
Q1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
6.
Kolostyák, Z., Bojcsuk, D., Baksa, V., Máthéné Szigeti, Z., Bene, K., Czimmerer, Z., Botó, P., Fadel, L., Póliska, S., Halász, L., Tzerpos, P., Berger, W. K., Villabona-Rueda, A., Varga, Z., Kovács, T., Patsalos, A., Pap, A., Vámosi, G., Bai, P., Dezső, B., Spite, M., D'Alessio,, F. R., Szatmári, I., Nagy, L.: EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages.
JCI Insight. 9 (17), 1-21, (article identifier: 164009), 2024.
Journal metrics:
D1 Medicine (miscellaneous)
7.
Mikó, E., Sipos, A., Tóth, E., Lehoczki, A., Fekete, M., Sebő, É., Kardos, G., Bai, P.: Guideline for designing microbiome studies in neoplastic diseases.
GeroScience. 46 (5), 4037-4057, 2024.
Journal metrics:
Q1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
Q1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
8.
Szántó, M., Yélamos, J., Bai, P.: Specific and shared biological functions of PARP2-is PARP2 really a lil' brother of PARP1?.
Expert Rev. Mol. Med. 26, 1-21, (article identifier: 13), 2024.
Journal metrics:
Q1 Molecular Biology
Q1 Molecular Medicine
9.
Schwarcz, S., Kovács, P., Nyerges, P., Ujlaki, G., Sipos, A., Uray, K., Bai, P., Mikó, E.: The bacterial metabolite, lithocholic acid, has antineoplastic effects in pancreatic adenocarcinoma.
Cell Death Discov. 10 (1), 1-12, 2024.
Journal metrics:
Q1 Cancer Research
Q1 Cell Biology
Q1 Cellular and Molecular Neuroscience
Q1 Immunology
10.
Papp, H., Tóth, E., Bóvári-Biri, J., Bánfai, K., Juhász, P., Mahdi, M., Russo, L. C., Bajusz, D., Sipos, A., Petri, L., Szalai, T. V., Kemény, Á., Madai, M., Kuczmog, A., Batta, G., Mózner, O., Vaskó, D., Hirsch, E., Bohus, P., Méhes, G., Tőzsér, J., Curtin, N., Helyes, Z., Tóth, A., Hoch, N. C., Jakab, F., Keserű, G. M., Pongrácz, J., Bai, P.: The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19.
Br. J. Pharmacol. 181 (23), 4782-4803, 2024.
Journal metrics:
D1 Pharmacology
2023
11.
Kacsir, I., Sipos, A., Kiss, T., Major, E., Bajusz, N., Tóth, E., Buglyó, P., Somsák, L., Kardos, G., Bai, P., Bokor, É.: Half sandwich-type osmium, ruthenium, iridium and rhodium complexes with bidentate glycosyl heterocyclic ligands induce cytostasis in platinum-resistant ovarian cancer cells and bacteriostasis in Gram-positive multiresistant bacteria.
Front. Chem. 11, 1-18, (article identifier: 1086267), 2023.
Journal metrics:
Q1 Chemistry (miscellaneous)
12.
Kacsir, I., Sipos, A., Major, E., Bajusz, N., Bényei, A., Buglyó, P., Somsák, L., Kardos, G., Bai, P., Bokor, É.: Half-sandwich type platinum-group metal complexes of C-Glucosaminyl azines: syntheses, antineoplastic and antimicrobial activities.
Molecules. 28 (7), 1-55, (article identifier: 3058), 2023.
Journal metrics:
Q1 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
13.
Ujlaki, G., Kovács, T., Vida, A., Kókai, E., Rauch, B., Schwarcz, S., Mikó, E., Janka, E. A., Sipos, A., Hegedűs, C., Uray, K., Nagy, P., Bai, P.: Identification of bacterial metabolites modulating breast cancer cell proliferation and epithelial-mesenchymal transition.
Molecules. 28 (15), 1-18, (article identifier: 5898), 2023.
Journal metrics:
Q1 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
14.
Kovács, T., Rauch, B., Mikó, E., Bai, P.: Methods to assess the role of PARPs regulating mitochondrial oxidative function.
In: Poly(ADP-Ribose) Polymerase: Methods and Protocols, Methods in Molecular Biology. Ed.: Tulin, A.V, Humana Press Inc, Totowa, 227-249, 2023. ISBN: 9781071628904
15.
Jankó, L., Tóth, E., Laczik, M., Rauch, B., Janka, E. A., Bálint, B. L., Bai, P.: PARP2 poly(ADP-ribosyl)ates nuclear factor erythroid 2-related factor 2 (NRF2) affecting NRF2 subcellular localization.
Sci. Rep. 13 (7869), 1-13, (article identifier: 7869), 2023.
Journal metrics:
D1 Multidisciplinary
16.
Antal, D., Pór, Á., Kovács, I., Dull, K., Póliska, S., Ujlaki, G., Demény, M. Á., Szöllősi, A. G., Kiss, B. K., Szegedi, A., Bai, P., Szántó, M.: PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes.
J. Mol. Med. (Berl). 101 (8), 987-999, 2023.
Journal metrics:
D1 Drug Discovery
Q1 Genetics (clinical)
Q1 Molecular Medicine
17.
Antal, D., Pór, Á., Kovács, I., Dull, K., Póliska, S., Ujlaki, G., Demény, M. Á., Szöllősi, A. G., Kiss, B. K., Szegedi, A., Bai, P., Szántó, M.: PARP2 promotes inflammation in sporiasis by modulating estradiol biosynthesis in keratinocytes.
In: FEBS Advanced Lecture Course: PARP 2023: Research on the family of poly(ADP-ribose) polymerases; Book of Abstracts. Ed.: Andreja Mikoc, Ivan Matic, Ruder Boskovic Institue, Hvar, 60, 2023. ISBN: 9789537941468
18.
Schwarcz, S., Kovács, P., Kovács, T., Ujlaki, G., Nyerges, P., Uray, K., Bai, P., Mikó, E.: The pro- and antineoplastic effects of deoxycholic acid in pancreatic adenocarcinoma cell models.
Mol. Biol. Rep. 50 (6), 5273-5282, 2023.
Journal metrics:
Q3 Genetics
Q2 Medicine (miscellaneous)
Q3 Molecular Biology
2022
19.
Lüscher, B., Ahel, I., Altmeyer, M., Ashworth, A., Bai, P., Chang, P., Cohen, M., Corda, D., Dantzer, F., Daugherty, M. D., Dawson, T. M., Dawson, V. L., Deindl, S., Fehr, A. R., Feijs, K. L. H., Filippov, D. V., Gagné, J. P., Grimaldi, G., Guettler, S., Hoch, N. C., Hottiger, M. O., Korn, P., Kraus, W. L., Ladurner, A., Lehtiö, L., Leung, A. K. L., Lord, C. J., Mangerich, A., Matic, I., Matthews, J., Moldovan, G. L., Moss, J., Natoli, G., Nielsen, M. L., Niepel, M., Nolte, F., Pascal, J., Paschal, B. M., Pawłowski, K., Poirier, G. G., Smith, S., Timinszky, G., Wang, Z. Q., Yélamos, J., Yu, X., Zaja, R., Ziegler, M.: ADP-ribosyltransferases, an update on function and nomenclature.
FEBS J. 289 (23), 7399-7410, 2022.
Journal metrics:
Q1 Biochemistry
Q1 Cell Biology
Q1 Molecular Biology
20.
Antal, D., Alimohammadi, S., Bai, P., Szöllősi, A. G., Szántó, M.: Antigen-Presenting Cells in Psoriasis.
Life (Basel). 12 (2), 1-10, (article identifier: 234), 2022.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q2 Ecology, Evolution, Behavior and Systematics
Q2 Paleontology
Q2 Space and Planetary Science
21.
Bai, P.: Az onkobiózis és a daganatok kapcsolata.
Orvostovábbk. szle. 29 (8), 79-83, 2022.
22.
Antal, D., Janka, E. A., Szabó, J., Szabó, I. L., Szegedi, A., Gáspár, K., Bai, P., Szántó, M.: Culture-based analyses of skin bacteria in lesional moist, and unaffected dry and sebaceous skin regions of hidradenitis suppurativa patients.
J. Eur. Acad. Dermatol. Venereol. 36 (9), e731-e733, 2022.
Journal metrics:
D1 Dermatology
Q1 Infectious Diseases
23.
Nagy, L., Rauch, B., Szerafin, T., Uray, K., Tóth, A., Bai, P.: Nicotinamide-riboside shifts the differentiation of human primary white adipocytes to beige adipocytes impacting substrate preference and uncoupling respiration through SIRT1 activation and mitochondria-derived reactive species production.
Front. Cell. Dev. Biol. 10, 1-12, (article identifier: 979330), 2022.
Journal metrics:
Q2 Cell Biology
Q1 Developmental Biology
24.
Wang, L., Wang, D., Sonzogni, O., Ke, S., Wang, Q., Thavamani, A., Batalini, F., Stopka, S. A., Regan, M. S., Vandal, S., Tian, S., Pinto, J., Cyr, A. M., Bret-Mounet, V. C., Baquer, G., Eikesdal, H. P., Yuan, M., Asara, J. M., Heng, Y. J., Bai, P., Agar, N. Y. R., Wulf, G. M.: PARP-inhibition reprograms macrophages toward an anti-tumor phenotype.
Cell Reports. 41 (2), 1-22, (article identifier: 111462), 2022.
Journal metrics:
D1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
25.
Antal, D., Pór, Á., Dull, K., Kovács, I., Szegedi, A., Bai, P., Szántó, M.: Poly(ADP-ribose) polymerase (PARP)-2 promotes inflammation in psoriasis by regulating estradiol biosynthesis in keratinocytes.
J. Invest. Dermatol. 142 (12), S237, 2022.
DEENK University of Debrecen
© 2012 University of Debrecen